Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.065 USD | +3.55% | -1.46% | +72.03% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.03% | 554M | |
+66.92% | 62.86B | |
-0.99% | 41.38B | |
+45.72% | 40.38B | |
-8.93% | 27.64B | |
+13.31% | 26.46B | |
-22.79% | 18.9B | |
+3.99% | 12.67B | |
+24.45% | 12.27B | |
+27.65% | 12.07B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Taysha Gene Therapies Gets Expanded Eligibility in Canada for Early Trial of Rett Syndrome Treatment